Flint, A. J., Meyers, B. S., Rothschild, A. J., Whyte, E. M., Alexopoulos, G. S., Rudorfer, M. V., . . . Group, S. I. S. (2019). Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. JAMA: Journal of the American Medical Association, 322(7), 622. https://doi.org/10.1001/jama.2019.10517
Chicago Style (17th ed.) CitationFlint, Alastair J., et al. "Effect of Continuing Olanzapine Vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial." JAMA: Journal of the American Medical Association 322, no. 7 (2019): 622. https://doi.org/10.1001/jama.2019.10517.
MLA (9th ed.) CitationFlint, Alastair J., et al. "Effect of Continuing Olanzapine Vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial." JAMA: Journal of the American Medical Association, vol. 322, no. 7, 2019, p. 622, https://doi.org/10.1001/jama.2019.10517.